Shares of Merus (NASDAQ:MRUS – Get Rating) dropped 5.5% during mid-day trading on Friday . The company traded as low as $27.40 and last traded at $27.40. Approximately 3,016 shares traded hands during mid-day trading, a decline of 97% from the average daily volume of 100,606 shares. The stock had previously closed at $29.00. MRUS […]
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.
Kestra Advisory Services LLC increased its holdings in shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL – Get Rating) by 236.5% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 33,650 shares of the company’s stock after acquiring an additional 23,650 shares during the quarter. […]
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Rating) saw a significant growth in short interest during the month of March. As of March 15th, there was short interest totalling 748,800 shares, a growth of 55.7% from the February 28th total of 480,900 shares. Based on an average daily volume of 176,000 shares, the short-interest ratio is […]
Wall Street analysts forecast that Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Rating) will report ($1.30) earnings per share (EPS) for the current quarter, Zacks reports. Four analysts have made estimates for Mirum Pharmaceuticals’ earnings. The lowest EPS estimate is ($1.47) and the highest is ($1.03). Mirum Pharmaceuticals posted earnings of ($1.68) per share in the […]